Related Experiment Video
Updated: Feb 22, 2026

Establishment of a High-throughput Setup for Screening Small Molecules That Modulate c-di-GMP Signaling in Pseudomonas aeruginosa
Published on: June 30, 2016
[Progress in c-di-GMP inhibitors]
Xuwen Xiang1,2,3, Xingyu Liu1,2,3, Hui Tao1,2,3
1State Key Laboratory for Conservation and Utilization of Subtropical Agro-bioresources, Guangzhou 510642, Guangdong, China.
Abstract:
The cyclic dinucleotide c-di-GMP is known as an important second messenger in bacteria, which controls various important cellular processes, such as cell differentiation, biofilm formation and virulence factors production. It is extremely vital for the development of new antibacterial agents by virtue of blocking c-di-GMP signal conduction. Current research indicates that there are three potential targets for discovering new antibacterial agents based on c-di-GMP regulated signal pathway, which are c-di-GMP synthases, c-di-GMP degrading enzymes and c-di-GMP receptors. Herein, we review small molecules that have been developed to inhibit c-di-GMP related enzymes and indicate perspectives of c-di-GMP inhibitors.

